Elevated biomarkers predict risk for prostate cancer recurrence

A simple blood test screening for a panel of biomarkers can accurately predict whether a patient who has had prostate cancer surgery will have a recurrence or spread of the disease.

If you want to include this story in your blog, copy and paste this formatted text: